ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: FR-PO078

Clinical Efficacy of Intraoperative Hemodialysis During Open-Heart Surgery with CKD Stage G4 and G5

Session Information

  • AKI: Clinical Outcomes, Trials
    November 08, 2019 | Location: Exhibit Hall, Walter E. Washington Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Acute Kidney Injury

  • 102 AKI: Clinical, Outcomes, and Trials

Authors

  • Inoue, Takahiro, Kameda Medical Center, Kamogawa, Japan
  • Kuji, Hiroshi, Kameda Medical Center, Kamogawa, Japan
  • Nagaoka, Kanako, Kameda Medical Center, Kamogawa, Japan
  • Akanuma, Takafumi, Kameda Medical Center, Kamogawa, Japan
  • Yu, Munakata, Munakata Clinic, Chiba, Japan
  • Watanabe, Yoshihiko, Munakata Clinic, Chiba, Japan
  • Fukuda, Junko, Kameda Medical Center, Kamogawa, Japan
  • Ohara, Mamiko, Kameda Medical Center, Kamogawa, Japan
  • Suzuki, Tomo, Kameda Medical Center, Kamogawa, Japan

Group or Team Name

  • Department of Nephrology , Kameda Medical Center
Background

Severe acute kidney injury after cardiac surgery frequently requires renal replacement therapy (RRT) and moreover increases mortality rates and a prolonged length of hospital stay. Recently, we performed intraoperative hemodialysis (IHD) during open-heart surgery for the patients with chronic kidney disease (CKD) to prevent postoperative RRT. However, the clinical implication is unclear, therefore we investigated the efficacy of IHD.

Methods

This is a single-center cohort study with patients undergoing non-emergency cardiac surgeries between Jan, 2008 to Dec, 2018 in our hospital. The subjects were 61 patients classified as CKD G4 or G5 without chronic dialysis and post-transplant. Until Aug 2013, patients underwent surgery without IHD. Since Sep, 2013, patients were dialyzed intraoperatively. We evaluated the efficacy of IHD, comparing an IHD group (IHD) with a non IHD group (non-IHD).

Results

Comparing IHD and non-IHD, the patient number was 19 vs. 28 (CKD G4) and 9 vs. 5 (CKD G5). Preoperative eGFR (CKD G4) was 19.1±5.6 vs. 22.0±5.2 mL/min/1.73m2 (p=0.039), and 19.1±5.6 vs. 22.0±5.2 (CKD G5). Diabetic mellitus accounted for 35.7% vs. 42.4% (P=0.384), and operative duration 331±99 vs. 295±65 min (p=0.16). Clinical characteristics and preoperative renal function were similar between two groups. Ninety-day mortality, hospital days, duration of postoperative intubation, renal function at discharge were not significantly different between IHD and non-IHD. Regarding CKD G4, the rate of RRT within 30 days after surgery (30-day RRT) was significant lower in IHD.

Conclusion

IHD had lower incidence of 30-day RRT than non-IHD in patients with CKD G4 prior to surgery.

Clinical features and Outcome between IHD group and non IHD group
patients undergoing cardiac surgery (N=61)IHD (N=28)non IHD (N=33)P value
Age,years74.5±7.072.9±9.40.744
Male, n, %17(60.7)16(50.3)0.339
Preoperative eGFR, G4 ml/min/1.73m2.22.2±3.723.8±3.20.123
G5 ml/min/1.73m219.1±5.622.0±5.20.663
CKDG4, n.19280.116
90-day mortality, %.7.13.00.482
30-day RRT G4, n, %0 (0)7 (25.0)0.037
G5, n, %5 (55.6)3 (60.0)0.933